A leading US pharmaceutical company was interested to understand the best in the class technology landscape in the Gene editing pl...
Sample Business Objective #1
Perspectives
Explore Strategic growth fields, hot topics and insights
Life Sciences
In-Licensing Opportunity Assessment
A leading research-based international pharmaceutical company was interested in enhancing its present portfolio by in-licensing an...
Life Sciences
Regulatory Pathway & Market Potential in the US
A large biopharma company was interested to understand the regulatory landscape & market opportunity to enter the US market wi...
Life Sciences
Indication Prioritization and Opportunity Selection
Quick overview
Our client needed support for the identification and selection of opportunities to grow and opti...
Digital Solutions for Orthopedic Surgeries
Medical Device & Diagnostics Minimally Invasive Surgery (MIS)
Quick overview
Our client was working towards digitalizing the various aspects related to patient management fo...
Combination Immunotherapy in Oncology: Harnessing the Power of Many
Life Sciences
The development of cancer immunotherapy for Immune checkpoint inhibitors (ICI) resistant cancers has been a challenge. Current ICI...
Role of Open Innovation and Consortium in Accelerating Drug Discovery
Life Sciences Digitalization
In recent years major pharmaceutical companies have re-organized their R&D structure via M&A, external partnerships, out-s...
Unmet Needs Addressable With Innovative Drug Delivery Approaches
Life Sciences Digitalization
With continuous innovation in the field of modern drug delivery systems, the client was interested in new therapy options to deliv...
Digital Biomarker in Neurological Patient-Centric Ecosystem
Life Sciences Digitalization
We helped a leading molecular diagnostic, personalized medicine company to adequately understand and prioritize State-of-the-art T...
Challenges in Clinical Trials and Potential Solutions
Life Sciences
Clinical trials are the only way of establishing the safety and efficacy of any drug before its introduction into the market for h...
Rare Cancers: Challenges and Roadmap for R&D Innovations
Life Sciences Paradigm Shift in R&D
Drug development for Rare cancers is challenging because it is difficult to obtain relevant data from very few patients. The oncol...
Open Innovation and Consortiums to Improve R and D Productivity, and Accelerating Drug Discovery
Life Sciences
In recent years major pharmaceutical companies have re-organized their R&D structure by forging external partnerships, mergers...
Disease-modifying Drugs (DMOADs) in Osteoarthritis
Life Sciences
Deterioration of the cartilage in joints is the peculiar characteristic of Osteoarthritis (OA). Currently approved therapies are f...
Challenges and Drivers of Translational Research
Life Sciences
Translational research is aimed at deploying knowledge collected from trials and clinical observations to improve clinical benefit...
